Christos Perisanidis

Professor

Clinic of Oral & Maxillofacial Surgery

 

Contact details

Phone: (+30) 210-746-1267
Email: cperis[at]dent.uoa[dot]gr

Mailing Address:
2 Thivon Str, 115 27 Athens, Greece

Profiles and publications

   

Education / Qualifications

• 1996: D.D.S. degree, School of Dentistry, Aristotle University of Thessaloniki, Greece.
• 2002: M.D. degree, University of Ioannina, Greece.
• 2014: Doctorate (Ph.D.) of the School of Dentistry, National and Kapodistrian University of Athens, Greece.

Clinical Specialty

• Surgical oncology of the mouth and oropharynx
• Microvascular rehabilitation with free flaps
• Surgery of the salivary glands
• Surgery of facial clefts
• Surgical implantology and tissue regeneration
• Orthognathic surgery

Academic and professional positions held

• 2018: Professor, Director of the Clinic of Oral and Maxillofacial Surgery, School of Dentistry, National and Kapodistrian University of Athens, Greece.
• 2016: Associate Professor-Director of the Department of Oral and Maxillofacial Oncology and Microvascular Surgery, Medical University of Vienna, Austria.
• 2013: Assistant Professor and Lecturer of Oral and Maxillofacial Surgery at the Medical University of Vienna, Austria.
• 2010: Oberarzt at the Department of Oral and Maxillofacial Surgery at the Medical University of Vienna.

Selected publications in scientific journals

• Dysregulation of ß-catenin, WISP1 and TCF21 predicts disease-specific survival and primary response against radio(chemo)therapy in patients with locally advanced squamous cell carcinomas of the head and neck. Vyskocil E, Pammer J, Altorjai G, Grasl MC, Parzefall T, Haymerle G, Janik S, Perisanidis C, Erovic BM. Clin Otolaryngol. 2019 Jan 7. doi: 10.1111/coa.13281.
• Accuracy of soft tissue prediction in surgery-first treatment concept in orthognathic surgery: A prospective study. Holzinger D, Juergens P, Shahim K, Reyes M, Schicho K, Millesi G, Perisanidis C, Zeilhofer HF, Seemann R. J Craniomaxillofac Surg. 2018 Sep;46(9):1455-1460.
• Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma. Strati A, Koutsodontis G, Papaxoinis G, Angelidis I, Zavridou M, Economopoulou P, Kotsantis I, Avgeris M, Mazel M, Perisanidis C, Sasaki C, Alix-Panabières C, Lianidou E, Psyrri A. Ann Oncol. 2017 Aug 1;28(8):1923-1933.
• Importance of chewing, saliva, and swallowing function in patients with advanced oral cancer undergoing preoperative chemoradiotherapy: a prospective study of quality of life. Nemeth D, Zaleczna L, Huremovic A, Engelmann J, Poeschl PW, Strasz M, Holawe S, Kornek G, Laskus A, Sacher C, Erovic BM, Perisanidis C. Int J Oral Maxillofac Surg. 2017 Oct;46(10):1229-1236.
• The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection. Russmueller G, Seemann R, Weiss K, Stadler V, Speiss M, Perisanidis C, Fuereder T, Willinger B, Sulzbacher I, Steininger C. Sci Rep. 2016 Aug 17;6:31604.
• Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis. Perisanidis C, Psyrri A, Cohen EE, Engelmann J, Heinze G, Perisanidis B, Stift A, Filipits M, Kornek G, Nkenke E. Cancer Treat Rev. 2015 Dec;41(10):960-70.
• Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma. Vassilakopoulou M, Avgeris M, Velcheti V, Kotoula V, Rampias T, Chatzopoulos K, Perisanidis C, Kontos CK, Giotakis AI, Scorilas A, Rimm D, Sasaki C, Fountzilas G, Psyrri A. Clin Cancer Res. 2016 Feb 1;22(3):704-13.
• Upregulation of osteoprotegerin expression correlates with bone invasion and predicts poor clinical outcome in oral cancer. Russmueller G, Moser D, Würger T, Wrba F, Christopoulos P, Kostakis G, Seemann R, Stadler V, Wimmer G, Kornek G, Psyrri A, Filipits M, Perisanidis C. Oral Oncol. 2015 Mar;51(3):247-53.
• Causes and timing of delayed bleeding after oral surgery. Czembirek C, Poeschl WP, Eder-Czembirek C, Fischer MB, Perisanidis C, Jesch P, Schicho K, Dong A, Seemann R. Clin Oral Investig. 2014 Jul;18(6):1655-61.
• HCRP1 expression status is a significant prognostic marker in oral and oropharyngeal cancer. Perisanidis C, Savarese-Brenner B, Würger T, Wrba F, Huynh A, Schopper C, Kornek G, Selzer E, Ewers R, Psyrri A, Krainer M, Filipits M. Oral Dis. 2013 Mar;19(2):206-11.